ScandiDos Announces First Order of Delta4 Discover in Mexico

ScandiDos AB, the global leader in Quality Assurance and Dosimetry for modern radiation therapy, has received the first order for its Delta4 Discover system in Mexico from the Instituto Mexicano del Sequro Social (IMSS).

UPPSALA, Sweden – ScandiDos AB (NASDAQ OMX First North: SDOS) is pleased to announce the first order of the Delta4 Discover system in Mexico. The Instituto Mexicano del Sequro Social (IMSS), the largest care provider in Mexico, has decided to introduce the Delta4 Discover for quality assurance of its radiotherapy. The order value is 171k Euro and delivery will be made this quarter. 

For more information about the Delta4 Discover system from ScandiDos, visit:

About ScandiDos AB
With its Delta4 Phantom, now updated as the Delta4 Phantom+, ScandiDos AB has assumed a leading role in advanced dosimetry and quality assurance of modern cancer radiation therapy. The Delta4 Discover, which is now validated for clinical use by Varian, allows clinics to provide radiation dosage verification during ongoing treatment of patients, thereby increasing the quality of the treatment and patient safety. The measurement system and advanced calculation programs from ScandiDos provide physicians, physicists and patients with validation that the advanced cancer radiation treatment is delivered precisely in the quantity and manner as planned.

Headquartered in Uppsala, Sweden, ScandiDos was founded in 2002 and has grown to include offices in Madison, Wis., Beijing and Paris. With its global footprint, ScandiDos has installed dosimetry and QA solutions in 45 countries, and its systems can be found in leading cancer centers worldwide. The company has partnership agreements with Varian and Elekta, which include ScandiDos products in their sales systems. Since April 2014, ScandiDos has been listed on NASDAQ First North Stockholm with the ticker symbol SDOS.

Date: November 15, 2018